These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7255522)

  • 1. The effects of lead, d-amphetamine, and time of day on activity levels in the mouse.
    Dolinsky Z; Fink E; Burright RG; Donovick PJ
    Pharmacol Biochem Behav; 1981 Jun; 14(6):877-80. PubMed ID: 7255522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of d-amphetamine upon open field behaviour in two inbred strains of mice.
    Moisset B; Welch BL
    Experientia; 1973 May; 29(5):625-6. PubMed ID: 4730313
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of varying doses of d-amphetamine on activity levels of prepubertal mice.
    Cytryn AS
    Psychiatry Res; 1980 Sep; 3(1):41-51. PubMed ID: 6934556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some effects of prenatal exposure to d-amphetamine sulfate and phenobarbital on developmental neurochemistry and on behavior.
    Zemp JW; Middaugh LD
    Addict Dis; 1975; 2(1-2):307-31. PubMed ID: 1163369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate-dependent effects of d-amphetamine on locomotor activity in mice: possible relationship to paradoxical amphetamine sedation in minimal brain dysfunction.
    Glick SD; Milloy S
    Eur J Pharmacol; 1973 Nov; 24(2):266-8. PubMed ID: 4797286
    [No Abstract]   [Full Text] [Related]  

  • 6. Caffeine pretreatment: enhancement and attenuation of d-amphetamine-induced activity.
    White BC; Keller GE
    Pharmacol Biochem Behav; 1984 Mar; 20(3):383-6. PubMed ID: 6709673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and ontogenetic variations in locomotor activity following treatment with scopolamine or d-amphetamine.
    Remington G; Anisman H
    Dev Psychobiol; 1976 Nov; 9(6):579-85. PubMed ID: 1001843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of d-amphetamine sulfate given to pregnant mice on activity and on catecholamines in the brains of offspring.
    Middaugh LD; Blackwell LA; Santos CA; Zemp JW
    Dev Psychobiol; 1974 Sep; 7(5):429-38. PubMed ID: 4426470
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of d-amphetamine and scopolamine on activity before and after shock in three mouse strains.
    Anisman H; Wahlsten D; Kokkinidis L
    Pharmacol Biochem Behav; 1975; 3(5):819-24. PubMed ID: 1208622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness to d-amphetamine in lead-exposed rats as measured by steady state levels of catecholamines and locomotor activity.
    Rafales LS; Greenland RD; Zenick H; Goldsmith M; Michaelson IA
    Neurobehav Toxicol Teratol; 1981; 3(3):363-7. PubMed ID: 7290291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thyroidectomy on amphetamine-induced acceleration of locomotor activity in mice.
    Ohashi K; Tadokoro S
    Jpn J Pharmacol; 1976 Oct; 26(5):621-4. PubMed ID: 1003712
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional brain distribution of alpha-amphetamine in lead-exposed rats.
    Zenick H; Lasley SM; Greenland R; Caruso V; Succop P; Price D; Michaelson IA
    Toxicol Appl Pharmacol; 1982 Jun; 64(1):52-63. PubMed ID: 7112584
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of undernutrition in animal models of hyperactivity.
    Loch RK; Rafales LS; Michaelson IA; Bornschein RL
    Life Sci; 1978 Jun; 22(22):1963-70. PubMed ID: 672438
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of carbon disulfide on motor function and responsiveness to d-amphetamine in rats.
    Tilson HA; Cabe PA; Ellinwood EH; Gonzalez LP
    Neurobehav Toxicol; 1979; 1(1):57-63. PubMed ID: 551304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 16. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral characterization of d- and l-amphetamine: neurochemical implications.
    Segal DS
    Science; 1975 Oct; 190(4213):475-7. PubMed ID: 1166317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent modulation by estrogen of amphetamine-induced hyperactivity in male rats.
    West CH; Michael RP
    Pharmacol Biochem Behav; 1986 Oct; 25(4):919-23. PubMed ID: 3786349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic amphetamine in BALB/cBy mice, a strain that is not stimulated by acute administration of amphetamine.
    Logan L; Seale TW; Cao W; Carney JM
    Pharmacol Biochem Behav; 1988 Nov; 31(3):675-82. PubMed ID: 3251250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal behavioural effects of maternal nicotine exposure in rats.
    Fung YK
    J Pharm Pharmacol; 1988 Dec; 40(12):870-2. PubMed ID: 2907580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.